Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide and inducible nitric oxide synthase by mouse macrophages

被引:36
作者
Riches, DWH
Chan, ED
Zahradka, EA
Winston, BW
Remigio, LK
Lake, FR
机构
[1] Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Biochem Biophys & Genet, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Pulm Sci, Denver, CO 80262 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[6] Univ Calgary, Dept Med, Div Crit Care Med, Calgary, AB T2N 4N1, Canada
[7] Univ Calgary, Dept Biochem, Div Crit Care Med, Calgary, AB T2N 4N1, Canada
[8] Univ Calgary, Dept Mol Biol, Div Crit Care Med, Calgary, AB T2N 4N1, Canada
关键词
D O I
10.1074/jbc.273.35.22800
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor-alpha (TNF alpha) is recognized by the cell-surface receptors CD120a (p55) and CD120b (p75). In the present study, we have investigated the role of these receptors in the expression of NO2- a stable metabolite of nitric oxide, and inducible nitric oxide synthase (iNOS) by mouse macrophages. Specific antibody-mediated aggregation of CD120a (p55) induced NO2- accumulation in culture supernatants and iNOS mRNA expression in macrophage lysates, whereas cross-linking of CD120b (p75) had a minimal effect. In contrast, simultaneous cross-linking of both receptors led to a marked augmentation in NO2- and iNOS mRNA expression. Antibody-mediated blockade of CD120a (p55) completely inhibited NO2- expression in response to TNF alpha, whereas blockade of CD120b (p75) reduced NO2- accumulation by similar to 50%. Specific Ligation of CD120a (p55) with either (i) human TNF alpha or (ii) by incubation with mouse TNF alpha following pretreatment of macrophages with blocking concentrations of anti-CD120b (p75) antibody resulted in a similar reduction in NO2- production in response to TNF alpha. Quantification of iNOS mRNA, protein, and NO2- expression during independent and coligation of CD120a (p55) and CD120b (p75) indicated that iNOS mRNA and protein expression was transient in nature when CD120a (p55) was cross-linked alone but was prolonged when both receptors were simultaneously cross-linked. In addition, cross-linking both receptors also led to a potentiation of NO2- accumulation in culture supernatants that was more pronounced at later time points. These findings suggest that while cross-linking of CD120a (p55) is necessary and sufficient for iNOS mRNA and NO(2)(-)expression, CD120b (p75) participates by (i) increasing the sensitivity of the cells to TNF alpha, probably by "passing" ligand to CD120a (p55), and (ii) initiating a signaling event that results in a more sustained induction of iNOS mRNA and protein and thereby augments the production of nitric oxide.
引用
收藏
页码:22800 / 22806
页数:7
相关论文
共 39 条
[1]  
ADAMS LB, 1991, J IMMUNOL, V147, P1642
[2]  
ADAMS LB, 1990, J IMMUNOL, V144, P2725
[3]  
BAUMANN H, 1993, J IMMUNOL, V151, P4248
[4]  
BECKERMAN KP, 1993, J IMMUNOL, V150, P888
[5]  
BERMUDEZ LE, 1993, CLIN EXP IMMUNOL, V91, P277
[6]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[7]   Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha [J].
Chan, ED ;
Winston, BW ;
Jarpe, MB ;
Wynes, MW ;
Riches, DWH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13169-13174
[8]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[9]  
DING AH, 1988, J IMMUNOL, V141, P2407
[10]  
GREEN SJ, 1990, J IMMUNOL, V144, P278